142 related articles for article (PubMed ID: 28002959)
1. Truncated Latrunculins as Actin Inhibitors Targeting Plasmodium falciparum Motility and Host Cell Invasion.
Johnson S; Rahmani R; Drew DR; Williams MJ; Wilkinson M; Tan YH; Huang JX; Tonkin CJ; Beeson JG; Baum J; Smith BJ; Baell JB
J Med Chem; 2016 Dec; 59(24):10994-11005. PubMed ID: 28002959
[TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Studies of Truncated Latrunculin Analogues with Antimalarial Activity.
Varghese S; Rahmani R; Drew DR; Beeson JG; Baum J; Smith BJ; Baell JB
ChemMedChem; 2021 Feb; 16(4):679-693. PubMed ID: 32929894
[TBL] [Abstract][Full Text] [Related]
3. Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity.
Kudrimoti S; Ahmed SA; Daga PR; Wahba AE; Khalifa SI; Doerksen RJ; Hamann MT
Bioorg Med Chem; 2009 Nov; 17(21):7517-22. PubMed ID: 19800245
[TBL] [Abstract][Full Text] [Related]
4. Semisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: biological evaluations, preliminary structure-activity relationship and molecular modeling studies.
Khanfar MA; Youssef DT; El Sayed KA
ChemMedChem; 2010 Feb; 5(2):274-85. PubMed ID: 20043312
[TBL] [Abstract][Full Text] [Related]
5. Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking.
Ahmed SA; Odde S; Daga PR; Bowling JJ; Mesbah MK; Youssef DT; Khalifa SI; Doerksen RJ; Hamann MT
Org Lett; 2007 Nov; 9(23):4773-6. PubMed ID: 17929935
[TBL] [Abstract][Full Text] [Related]
6. Total synthesis of (+)-18-epi-latrunculol A: development of a synthetic route.
Williams BD; Smith AB
J Org Chem; 2014 Oct; 79(19):9284-96. PubMed ID: 25243951
[TBL] [Abstract][Full Text] [Related]
7. Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.
Sayed KA; Khanfar MA; Shallal HM; Muralidharan A; Awate B; Youssef DT; Liu Y; Zhou YD; Nagle DG; Shah G
J Nat Prod; 2008 Mar; 71(3):396-402. PubMed ID: 18298079
[TBL] [Abstract][Full Text] [Related]
8. Total syntheses of the actin-binding macrolides latrunculin A, B, C, M, S and 16-epi-latrunculin B.
Fürstner A; De Souza D; Turet L; Fenster MD; Parra-Rapado L; Wirtz C; Mynott R; Lehmann CW
Chemistry; 2007; 13(1):115-34. PubMed ID: 17091520
[TBL] [Abstract][Full Text] [Related]
9. Diversity-oriented synthesis and activity evaluation of substituted bicyclic lactams as anti-malarial against Plasmodium falciparum.
Sharma V; Agarwal S; Madurkar SM; Datta G; Dangi P; Dandugudumula R; Sen S; Singh S
Malar J; 2014 Nov; 13():467. PubMed ID: 25431142
[TBL] [Abstract][Full Text] [Related]
10. Exploiting a basic chemosensitizing pharmacophore hypothesis. Part 1: synthesis and biological evaluation of novel arylbromide and bicyclic chemosensitizers against drug-resistant malaria parasites.
Chouteau F; Ramanitrahasimbola D; Rasoanaivo P; Chibale K
Bioorg Med Chem Lett; 2005 Jun; 15(12):3024-8. PubMed ID: 15908208
[TBL] [Abstract][Full Text] [Related]
11. Bioactive natural and semisynthetic latrunculins.
El Sayed KA; Youssef DT; Marchetti D
J Nat Prod; 2006 Feb; 69(2):219-23. PubMed ID: 16499319
[TBL] [Abstract][Full Text] [Related]
12. Antiprotozoal activities of new bis-chlorophenyl derivatives of bicyclic octanes and aza-nonanes.
Berger H; Seebacher W; Saf R; Kaiser M; Brun R; Weis R
Bioorg Med Chem Lett; 2006 Oct; 16(20):5457-61. PubMed ID: 16889962
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial activity of yingzhaosu A analogues.
Kim HS; Begum K; Ogura N; Wataya Y; Tokuyasu T; Masuyama A; Nojima M; McCullough KJ
J Med Chem; 2002 Oct; 45(21):4732-6. PubMed ID: 12361400
[TBL] [Abstract][Full Text] [Related]
14. Squalestatin is an inhibitor of carotenoid biosynthesis in Plasmodium falciparum.
Gabriel HB; Silva MF; Kimura EA; Wunderlich G; Katzin AM; Azevedo MF
Antimicrob Agents Chemother; 2015; 59(6):3180-8. PubMed ID: 25779575
[TBL] [Abstract][Full Text] [Related]
15. Latrunculin analogues with improved biological profiles by "diverted total synthesis": preparation, evaluation, and computational analysis.
Fürstner A; Kirk D; Fenster MD; Aïssa C; De Souza D; Nevado C; Tuttle T; Thiel W; Müller O
Chemistry; 2007; 13(1):135-49. PubMed ID: 17091521
[TBL] [Abstract][Full Text] [Related]
16. Wide-ranging effects of eight cytochalasins and latrunculin A and B on intracellular motility and actin filament reorganization in characean internodal cells.
Foissner I; Wasteneys GO
Plant Cell Physiol; 2007 Apr; 48(4):585-97. PubMed ID: 17327257
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.
Hoelz LV; Calil FA; Nonato MC; Pinheiro LC; Boechat N
Future Med Chem; 2018 Aug; 10(15):1853-1874. PubMed ID: 30019917
[TBL] [Abstract][Full Text] [Related]
18. Diverted total synthesis: preparation of a focused library of latrunculin analogues and evaluation of their actin-binding properties.
Fürstner A; Kirk D; Fenster MD; Aïssa C; De Souza D; Müller O
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8103-8. PubMed ID: 15917332
[TBL] [Abstract][Full Text] [Related]
19. Divergent approach to building a latrunculin family derived hybrid macrocyclic toolbox.
Aeluri M; Dasari B; Arya P
Org Lett; 2015 Feb; 17(3):472-5. PubMed ID: 25583127
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Antimalarial Activity of Different Inhibitors of the Plasmodial Isoprenoid Synthesis Pathway.
da Silva MF; Saito AY; Peres VJ; Oliveira AC; Katzin AM
Antimicrob Agents Chemother; 2015 Aug; 59(8):5084-7. PubMed ID: 26055383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
